Short Interest in Dominari Holdings Inc. (NASDAQ:DOMH) Increases By 396.4%

Dominari Holdings Inc. (NASDAQ:DOMH) saw a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 41,200 shares, a growth of 396.4% from the December 15th total of 8,300 shares. Based on an average daily volume of 27,200 shares, the short-interest ratio is currently 1.5 days. Currently, 1.2% of the shares of the stock are short sold.

Dominari Stock Down 1.0 %

DOMH traded down $0.01 on Tuesday, hitting $1.03. The company had a trading volume of 34,326 shares, compared to its average volume of 75,378. The company has a market cap of $6.53 million, a PE ratio of -0.27 and a beta of 1.03. Dominari has a 12-month low of $0.83 and a 12-month high of $3.20. The business’s fifty day simple moving average is $1.45 and its 200 day simple moving average is $1.67.

Dominari (NASDAQ:DOMH) last posted its quarterly earnings data on Friday, November 8th. The company reported ($0.45) EPS for the quarter. The firm had revenue of $4.04 million for the quarter. Dominari had a negative return on equity of 32.89% and a negative net margin of 180.22%.

Dominari Company Profile

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.